GTx
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch GTx and buy or sell other stocks, ETFs, and their options commission-free!About GTXI
Oncternal Therapeutics, Inc. engages in the development of novel oncology therapies for the treatment of cancers with critical unmet medical need. Its product pipeline include Zilovertamab, ONCT-216, ONCT-808 and ONCT-534.
CEOJames B. Breitmeyer, MD, PhD
CEOJames B. Breitmeyer, MD, PhD
Employees—
Employees—
HeadquartersSan Diego, California
HeadquartersSan Diego, California
Founded1997
Founded1997
Employees—
Employees—
GTXI Key Statistics
Market cap1.56M
Market cap1.56M
Price-Earnings ratio-0.05
Price-Earnings ratio-0.05
Dividend yield—
Dividend yield—
Average volume—
Average volume—
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$0.5266
52 Week high$0.5266
52 Week low$0.5266
52 Week low$0.5266
Stock Snapshot
With a market cap of 1.56M, GTx(GTXI) trades at $3.94. The stock has a price-to-earnings ratio of -0.05.
GTx(GTXI) stock opened on 2025-12-09 at —. The price climbed to — and dipped to —.
GTx(GTXI) shares are trading with a volume of 0.
In the last year, GTx(GTXI) shares hit a 52-week high of $0.53 and a 52-week low of $0.53.
In the last year, GTx(GTXI) shares hit a 52-week high of $0.53 and a 52-week low of $0.53.